About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,539 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,539 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 7281-7300 of 7,539 trials

CompletedPhase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following ProstatectomyThis is a Phase 1 dose escalation study of an investigational agent, everolimus, given in combination with standard radiation therapy, in prostate cancers with a rising PSA…NCT01548807·Philadelphia, Pennsylvania UnknownCIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITIONObservational prospective study investigating the plasmatic levels of miRNA according to AR-V7 mutational status in mCRPC patients receiving standard of care therapy.NCT04188275·Florence CompletedEffects of IAS in Men With Localized Biochemical Relapsed Prostate CancerThis study was a prospective analysis in men with localized prostate cancer who had rising Prostate Specific Antigen (PSA) levels after definitive treatment with surgery or…NCT00223665·Seattle, Washington

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

RecruitingDiagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active SurveillanceThis investigator-initiated, prospective study evaluates the diagnostic utility of rhPSMA-7.3 (¹⁸F) PET/CT (flotufolastat F18, marketed as POSLUMA®) in men with biopsy-proven…NCT07285057·New York, New York

WithdrawnHyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate CancerThis phase II trial studies how well hyperpolarized carbon C 13 pyruvate magnetic resonance spectroscopic imaging works in predicting treatment response in patients with prostate…NCT03581500·Houston, Texas

RecruitingPSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate CancerProstate cancer remains the most common malignancy in men in Europe.NCT06652607·Rome, Lazio

CompletedTaxane Acute Pain Syndrome (TAPS) in Patients Receiving Taxane Chemotherapy for Breast or Prostate CancerThe purpose of this study is to document what course of action physicians choose for their patients when they develop taxane acute pain syndrome (TAPS) and to identify patients at…NCT02362087·Ottawa, Ontario

Active not recruitingA Trial of Ipatasertib in Combination With AtezolizumabThis is a single centre, proof-of-concept phase I trial of atezolizumab in combination with ipatasertib.NCT03673787·Sutton, Surrey

TerminatedExternal Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate CancerPrimary Objective: * To assess the possible improvement in prostate specific antigen (PSA) outcome of short course androgen suppression therapy in conjunction with…NCT00388804·Houston, Texas

CompletedCombination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate CancerRATIONALE: Some drugs used in chemotherapy can reduce the pain experienced by some people with cancer. Combining more than one drug may be more effective at reducing cancer pain.NCT00003232·Calgary, Alberta and 20 others

CompletedStudy of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate CancerRadiation sometimes affects the ability for a person to have a normal erection. Complete loss of erections after radiation treatment can happen in 40-50% of treated patients.NCT00142506·Basking Ridge, New Jersey and 4 others

RecruitingOxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled TrialThe goal of this double-blind, randomized, placebo-controlled study is to evaluate whether oxybutynin chloride extended-release tablets can improve early continence recovery after…NCT06966778·Taipei

WithdrawnIrreversible Electroporation(IRE) For Unresectable Prostatic NeoplasmsThe purpose of this study is to evaluate the safety and efficacy of irreversible electroporation (IRE) for unresectable Prostatic Neoplasms.NCT02430649·Guangzhou, Guangdong

Active not recruitingPhase Ia/Ib Talazoparib + Tazemetostat for mCRPCThis trial is testing whether molecularly targeted oral medications called talazoparib and tazemetostat can be safely combined for the treatment of prostate cancer, and whether…NCT04846478·Boston, Massachusetts and 1 other

CompletedRole of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)Randomized trials have already demonstrated that geriatric intervention was able to improve survival in the general elderly population but only a few have been performed in cancer…NCT02704832·Grenoble, Auvergne-Rhône-Alpes and 49 others

UnknownThe Impact of Medication Timing Adjustment on the Effect of Novel Hormonal TherapyThe purpose of this study is to assess the impact of medication timing adjustment on the effect of novel hormonal therapy (NHT) agents in patients with metastatic…NCT06505278·Guangzhou, Guangdong

RecruitingRadiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPCThis multi-center randomized controlled phase II trial was carried out in several hospitals in China to evaluate the efficacy and safety of radiotherapy or radical prostatectomy…NCT06992232·Nanjing, Jiangsu

CompletedStudy of XB002 in Subjects With Solid Tumors (JEWEL-101)This is a Phase 1, open-label, multicenter, dose-escalation and expansion study evaluating the safety, tolerability, PK, pharmacodynamics, and clinical antitumor activity of XB002…NCT04925284·Birmingham, Alabama and 94 others

CompletedObservational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate CancerObservational study in the routine clinical practice setting to evaluate the short and long term safety profile of Radium-223 in metastatic castration resistant prostate cancer…NCT02141438·Anchorage, Alaska and 67 others

RecruitingPrecision-Based Genomics in Prostate CancerBackground: Prostate cancer is the most common cancer and the second leading cause of death in males in the United States.NCT04706663·La Jolla, California and 10 others

PreviousPage 365 of 377Next